2023 and Beyond: The Future of Biotech

In this episode of Breakthrough Economy, we discuss the shifts and advances we saw in biotech in 2022, and what's to come in 2023 and beyond for this innovative sector. Host Jen Rogers is joined by George Yancopoulos, Co-Founder, President and Chief Scientific Officer at Regeneron and Managing Director and Senior Biotech Analyst at Oppenheimer, Hartaj Singh.

[@TheTobacko1]

INVITAE is a great company🎉🎉🎉🎉🎉🎉🎉🎉🎉

[@amazai]

Hi, I am PhD in Biotech and have no job. What should I do?

[@Louisianish]

I hear Theranos is a good company with a lot of potential to work for.

[@amazai]

@@Louisianish thanks for kind info

[@qjatoi57]

@@Louisianish lmao

[@gameplayplanet5015]

Join a biotech focused on gene therapy for eye diseases. The eye is the ideal place to try new biotechnology, and there is an unmet medical need for blind patients.

[@Diyorbek_Ikhtiyorov]

you don't have a PhD in biology. This is because you are religious, thus you don't believe in evolution, the most important concept in biology. Almost all biologists are atheists. Also no religious person would major in biology or biotech, this statement is even stronger in muslim perspective. Also a person who has a Phd is strongly motivated to that field of study. There is no way that any academic can not find any job. Stop fooling yourself and others, creationist.

[@jackpaperhands]

Rightsizing...ffs